Request for Proposals for Molecular Tests for STIs

This document is a Request for Proposals (RFP) issued by FIND, seeking manufacturers of true point-of-care molecular tests for Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT). The objective is to accelerate product development and market entry of these tests in low- and middle-income countries (LMICs). The document outlines the need for rapid molecular diagnostic tests to prevent inadequate antimicrobial use due to current syndromic management practices. It specifies the eligibility criteria for developers and manufacturers, requiring existing dual NG/CT molecular assays at a technology readiness level (TRL) of 4 or above. The RFP also details the expected project timeline, application deadline, and potential co-funding opportunities with the RIGHT Foundation. Additionally, it describes the benefits for applicants, including funding for independent evaluations and product optimization to meet operational requirements for primary healthcare settings in LMICs.